Skip to main content
Nxera Pharma Co., Ltd. logo

Nxera Pharma Co., Ltd. — Investor Relations & Filings

Ticker · 4565 ISIN · JP3431300007 LEI · 2138004M62BFNJMR2Z82 T Manufacturing
Open in API
Filings indexed 113 across all filing types
Latest filing 2021-05-12 Interim / Quarterly Rep…
Country JP Japan
Listing T 4565

About Nxera Pharma Co., Ltd.

https://www.nxera.life/

Nxera Pharma Co., Ltd. (formerly Sosei Group Corp.) is a technology-driven biopharmaceutical company focused on the discovery and early development of novel medicines. The company utilizes its proprietary StaR® technology and world-leading expertise in G protein-coupled receptor (GPCR) structure-based drug design (SBDD) to create therapeutics for diseases with high unmet medical needs. By integrating advanced science and technology, Nxera Pharma develops its internal pipeline and collaborates with partners to accelerate the creation of life-changing treatments for patients worldwide. Its mission is to invest in science and technology to accelerate the development of these medicines.

Recent filings

Filing Released Lang Actions
四半期報告書－第32期第1四半期(令和3年1月1日－令和3年3月31日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Sosei Group Corporation, covering the period from January 1, 2021, to March 31, 2021. It includes detailed financial statements, management analysis (MDA), and business updates, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2021
2021-05-12 Japanese
内部統制報告書－第31期(令和2年1月1日－令和2年12月31日)
Governance Information Classification · 100% confidence The document is an 'Internal Control Report' (内部統制報告書) filed under the Financial Instruments and Exchange Act of Japan. It details the company's framework, scope, and evaluation results regarding internal controls over financial reporting. This type of regulatory filing, which is distinct from a full annual report (10-K) or a simple announcement, falls under the category of regulatory filings or audit-related disclosures. Given the specific nature of the document as a mandatory regulatory disclosure regarding internal control systems, 'RNS' (Regulatory Filings) is the most appropriate classification.
2021-03-24 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is titled '確認書' (Confirmation Letter) and explicitly references '金融商品取引法第24条の４の２第１項' (Article 24-4-2, Paragraph 1 of the Financial Instruments and Exchange Act). It serves as an officer certification regarding the accuracy of a previously filed Annual Securities Report (有価証券報告書). According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type. FY 2020
2021-03-24 Japanese
有価証券報告書－第31期(令和2年1月1日－令和2年12月31日)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the standard annual financial filing required by the Financial Services Agency of Japan under the Financial Instruments and Exchange Act. It contains comprehensive financial statements, management discussion, and corporate information for the fiscal year ending December 31, 2020. This corresponds to the definition of an Annual Report (10-K). FY 2020
2021-03-24 Japanese
四半期報告書－第31期第3四半期(令和2年7月1日－令和2年9月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Sosei Group Corporation, covering the period from July 1, 2020, to September 30, 2020. It includes detailed financial statements, management analysis (MDA), and business updates, which are characteristic of an Interim/Quarterly Report (IR). It is not an announcement (RPA) because it contains the full substantive financial data and regulatory disclosures required for a quarterly filing under the Financial Instruments and Exchange Act. 9M 2020
2020-11-11 Japanese
四半期報告書－第31期第2四半期(令和2年4月1日－令和2年6月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Sosei Group Corporation, covering the period from April 1, 2020, to June 30, 2020. It contains detailed financial statements, management analysis, and business updates, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2020
2020-08-13 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.